March 17, 2020 / 4:03 PM / 18 days ago

BRIEF-Aytu Bioscience Announces Acceleration Of U.S. Availability Of Covid-19 Igg/Igm Rapid Test

March 17 (Reuters) - Aytu BioScience Inc:

* AYTU BIOSCIENCE INC - ANNOUNCES ACCELERATION OF U.S. AVAILABILITY OF COVID-19 IGG/IGM RAPID TEST BASED ON UPDATED FDA POLICY

* AYTU BIOSCIENCE INC - BELIEVE FDA’S UPDATED POLICY MAY ENABLE NEAR-TERM AVAILABILITY OF OUR RECENTLY-LICENSED POINT-OF-CARE TEST

* AYTU BIOSCIENCE INC - COMPANY WILL CONTINUE TO PROVIDE UPDATES ABOUT NEAR-TERM AVAILABILITY OF COVID-19 TEST Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below